Liu He Selected Research

Atrial Fibrillation

4/2024	Efficiency and Durability of EIVOM on Acute Reconnection After Mitral Isthmus Bidirectional Block.
2/2024	Data-driven classification of left atrial morphology and its predictive impact on atrial fibrillation catheter ablation.
1/2024	Catheter ablation of atrial fibrillation in patients with left bundle branch block.
12/2023	Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With Diabetes: A Propensity-Score Matching Study and Meta-Analysis.
12/2023	Impact of diagnosis-to-ablation time on clinical outcomes in patients with early-onset atrial fibrillation.
11/2023	Effect of SGLT2 inhibitors on cardiovascular events in patients with atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials.
11/2023	Impact of pre-ablation left appendage flow velocities on long term recurrence of catheter ablation for paroxysmal atrial fibrillation.
10/2023	Catheter ablation versus medical therapy for atrial fibrillation with prior stroke history: a prospective propensity score-matched cohort study.
10/2023	ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry.
10/2023	The ABC-Death Score for Mortality Prediction in Patients With Atrial Fibrillation Undergoing Catheter Ablation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liu He Research Topics

Disease

31	Atrial Fibrillation 04/2024 - 04/2019
18	Neoplasms (Cancer) 01/2024 - 12/2008
10	Stroke (Strokes) 10/2023 - 06/2011
7	Hemorrhage 12/2023 - 12/2020
6	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 03/2016
4	Pain (Aches) 10/2023 - 10/2016
4	Thromboembolism 10/2023 - 04/2019
4	Ischemic Stroke 01/2023 - 01/2021
4	Heart Failure 01/2022 - 04/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 12/2008
3	Stomach Neoplasms (Stomach Cancer) 01/2024 - 08/2020
3	Embolism (Embolus) 12/2023 - 05/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 03/2024 - 12/2022
2	Cognitive Dysfunction 02/2024 - 01/2021
2	Acne Vulgaris 02/2024 - 02/2023
2	Postoperative Pain 10/2023 - 01/2022
2	Diabetes Mellitus 12/2022 - 07/2020
2	Fibrosis (Cirrhosis) 07/2022 - 11/2015
2	Acute Coronary Syndrome 01/2022 - 07/2020
2	Thyroid Neoplasms (Thyroid Cancer) 07/2021 - 01/2015
2	Wounds and Injuries (Trauma) 01/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 10/2017 - 03/2016
2	Obesity 08/2017 - 06/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2015 - 08/2015
2	Flushing 08/2015 - 11/2012
2	Type 2 Diabetes Mellitus (MODY) 09/2009 - 06/2009
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2024
1	Epilepsy (Aura) 01/2024
1	Bundle-Branch Block (Fascicular Block) 01/2024
1	Melanoma (Melanoma, Malignant) 10/2023
1	Transient Ischemic Attack 10/2023
1	Death (Near-Death Experience) 10/2023
1	Autoimmune Diseases (Autoimmune Disease) 07/2023
1	Frailty 01/2023
1	Lymphoma (Lymphomas) 01/2023

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2021
8	AnticoagulantsIBA 01/2022 - 04/2019
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2006
4	Peptides (Polypeptides)IBA 02/2024 - 01/2021
4	Anti-Arrhythmia AgentsIBA 01/2023 - 06/2019
4	Neuroprotective AgentsIBA 01/2019 - 03/2016
3	LipidsIBA 04/2022 - 09/2009
3	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 04/2019
3	CholesterolIBA 01/2021 - 06/2011
3	InflammasomesIBA 11/2019 - 01/2018
3	Heparin (Liquaemin)FDA LinkGeneric 03/2016 - 11/2012
2	NAD (NADH)IBA 03/2024 - 12/2022
2	Sodium-Glucose Transport ProteinsIBA 12/2023 - 11/2023
2	Ropivacaine (Naropin)FDA LinkGeneric 10/2023 - 01/2022
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2023 - 01/2022
2	Polysaccharides (Glycans)IBA 02/2023 - 12/2022
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 02/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2020
2	Indicators and Reagents (Reagents)IBA 01/2023 - 04/2011
2	CytokinesIBA 10/2022 - 11/2015
2	oxidized low density lipoproteinIBA 04/2022 - 01/2021
2	LDL CholesterolIBA 04/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2011
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 07/2020
2	ChitosanIBA 10/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 09/2009
2	HDL CholesterolIBA 01/2021 - 06/2011
2	Therapeutic UsesIBA 01/2021 - 10/2016
2	N(4)-oleylcytosine arabinosideIBA 01/2021 - 04/2019
2	Sodium Chloride FDA LinkGeneric 08/2015 - 11/2012
2	Saline SolutionIBA 08/2015 - 11/2012
2	SolutionsIBA 08/2015 - 11/2012
1	Topoisomerase InhibitorsIBA 01/2024
1	Epirubicin (Ellence)FDA LinkGeneric 01/2024
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2024
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2024
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2024
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2024
1	PepsinogensIBA 01/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023
1	Troponin T (Troponin T1)IBA 10/2023
1	pro-brain natriuretic peptide (1-76)IBA 10/2023
1	OligopeptidesIBA 02/2023
1	Testosterone (Sustanon)FDA Link 02/2023
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2023
1	Hyaluronic Acid (Hyaluronan)IBA 02/2023
1	AZD4547IBA 02/2023
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 02/2023
1	Androgen Receptors (Androgen Receptor)IBA 02/2023
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2023
1	Aldo-Keto Reductase Family 1 Member C3IBA 02/2023

Therapy/Procedure

17	Catheter Ablation 04/2024 - 01/2021
8	Therapeutics 10/2023 - 01/2020
6	Radiofrequency Ablation 04/2024 - 09/2020
3	Drug Therapy (Chemotherapy) 01/2022 - 10/2021
2	Catheters 10/2023 - 08/2015
2	Immunotherapy 01/2023 - 01/2022
2	Neoadjuvant Therapy 10/2017 - 08/2017
1	Baths 03/2024
1	Cognitive Training 02/2024
1	Electrodes (Electrode) 01/2024
1	Patient Readmission 12/2023
1	Analgesia 10/2023